Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Immune complex binding (decoy) refers to a class of molecules—often termed *decoy receptors* or *decoys*—that bind immune complexes, ligands, or antibodies in the extracellular space. By doing so, they prevent these immune mediators from interacting with their natural cellular targets and modulate downstream signaling pathways. Decoy mechanisms are crucial in regulating inflammation, autoimmunity, and pathogen defense.
Competitive inhibition of ligand binding to cellular receptors, leading to neutralization of the ligand's biological activity and prevention of downstream signaling.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Immune Complex Binding (Decoy).